Experienced in Keloids

Claus M. Rodel

Frankfurt Am Main, HE, DE 
Experienced in Keloids
Frankfurt Am Main, HE, DE 
OverviewLocationsClinical Research

Overview

Claus Rodel practices in Frankfurt Am Main, Germany. Mr. Rodel is rated as an Experienced expert by MediFind in the treatment of Keloids. His top areas of expertise are Colorectal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Anal Cancer, Cystectomy, and Prostatectomy.

His clinical research consists of co-authoring 263 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Keloids.

Gender
Male

Locations

Frankfurt Am Main, HE 60590, Germany
Other Locations
Heidelberg, BW, Germany
Dresden, SN, Germany
Berlin, BE, Germany
Munich, BY, Germany
Essen, NW, Germany
Wolfgang, HE, Germany
Erlangen, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Capecitabine-based Chemoradiotherapy in Combination With the IL-1 Receptor Antagonist Anakinra for Rectal Cancer Patients. A Phase I Trial of the German Rectal Cancer Study Group
Capecitabine-based Chemoradiotherapy in Combination With the IL-1 Receptor Antagonist Anakinra for Rectal Cancer Patients. A Phase I Trial of the German Rectal Cancer Study Group
Enrollment Status: Completed
Publish Date: February 21, 2025
Intervention Type: Procedure, Drug, Radiation
Study Phase: Phase 1
Significance of Chemoradiation Following Induction Chemotherapy in Locally Advanced,Unresectable Pancreatic Cancer -a Randomised Phase 3 Trial: Chemoradiation Following Induction Chemotherapy Compared With Chemotherapy Alone
Significance of Chemoradiation Following Induction Chemotherapy in Locally Advanced,Unresectable Pancreatic Cancer -a Randomised Phase 3 Trial: Chemoradiation Following Induction Chemotherapy Compared With Chemotherapy Alone
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug, Radiation
Study Drugs: Gemcitabine, FOLFIRINOX
Study Phase: Phase 3
Observational Study on Biomarkers in Head and Neck Cancer
Observational Study on Biomarkers in Head and Neck Cancer
Enrollment Status: Completed
Publish Date: August 03, 2022
Intervention Type: Biological
View 2 Less Clinical Trials

263 Total Publications

HDR Mould-Based Brachytherapy for Cutaneous Neoplasms: Toxicity, Long-Term Control, Cosmesis and PROMs.
HDR Mould-Based Brachytherapy for Cutaneous Neoplasms: Toxicity, Long-Term Control, Cosmesis and PROMs.
Journal: Dermatology and therapy
Published: August 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rodel's expertise for a condition
ConditionClose
View All 28 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile